Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans.

Blanco I, Mathai S, Shafiq M, Boyce D, Kolb TM, Chami H, Hummers LK, Housten T, Chaisson N, Zaiman AL, Wigley FM, Tedford RJ, Kass DA, Damico R, Girgis RE, Hassoun PM.

Medicine (Baltimore). 2014 Jul;93(5):177-85. doi: 10.1097/MD.0000000000000032.

2.

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.

Tedford RJ, Mudd JO, Girgis RE, Mathai SC, Zaiman AL, Housten-Harris T, Boyce D, Kelemen BW, Bacher AC, Shah AA, Hummers LK, Wigley FM, Russell SD, Saggar R, Saggar R, Maughan WL, Hassoun PM, Kass DA.

Circ Heart Fail. 2013 Sep 1;6(5):953-63.

3.

Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patients.

Cheadle C, Berger AE, Mathai SC, Grigoryev DN, Watkins TN, Sugawara Y, Barkataki S, Fan J, Boorgula M, Hummers L, Zaiman AL, Girgis R, McDevitt MA, Johns RA, Wigley F, Barnes KC, Hassoun PM.

PLoS One. 2012;7(4):e34951. doi: 10.1371/journal.pone.0034951. Epub 2012 Apr 24.

4.

Digoxin inhibits development of hypoxic pulmonary hypertension in mice.

Abud EM, Maylor J, Undem C, Punjabi A, Zaiman AL, Myers AC, Sylvester JT, Semenza GL, Shimoda LA.

Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1239-44. doi: 10.1073/pnas.1120385109. Epub 2012 Jan 9.

5.

A critical role for the protein apoptosis repressor with caspase recruitment domain in hypoxia-induced pulmonary hypertension.

Zaiman AL, Damico R, Thoms-Chesley A, Files DC, Kesari P, Johnston L, Swaim M, Mozammel S, Myers AC, Halushka M, El-Haddad H, Shimoda LA, Peng CF, Hassoun PM, Champion HC, Kitsis RN, Crow MT.

Circulation. 2011 Dec 6;124(23):2533-42. doi: 10.1161/CIRCULATIONAHA.111.034512. Epub 2011 Nov 14.

6.

MicroRNA profiling of diverse endothelial cell types.

McCall MN, Kent OA, Yu J, Fox-Talbot K, Zaiman AL, Halushka MK.

BMC Med Genomics. 2011 Nov 2;4:78. doi: 10.1186/1755-8794-4-78.

7.

Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload.

Koitabashi N, Danner T, Zaiman AL, Pinto YM, Rowell J, Mankowski J, Zhang D, Nakamura T, Takimoto E, Kass DA.

J Clin Invest. 2011 Jun;121(6):2301-12. doi: 10.1172/JCI44824. Epub 2011 May 2.

8.

Phosphodiesterase-5A (PDE5A) is localized to the endothelial caveolae and modulates NOS3 activity.

Gebska MA, Stevenson BK, Hemnes AR, Bivalacqua TJ, Haile A, Hesketh GG, Murray CI, Zaiman AL, Halushka MK, Krongkaew N, Strong TD, Cooke CA, El-Haddad H, Tuder RM, Berkowitz DE, Champion HC.

Cardiovasc Res. 2011 May 1;90(2):353-63. doi: 10.1093/cvr/cvq410. Epub 2011 Mar 18.

9.

Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.

Campo A, Mathai SC, Le Pavec J, Zaiman AL, Hummers LK, Boyce D, Housten T, Champion HC, Lechtzin N, Wigley FM, Girgis RE, Hassoun PM.

Am J Respir Crit Care Med. 2010 Jul 15;182(2):252-60. doi: 10.1164/rccm.200912-1820OC. Epub 2010 Mar 25.

10.

PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support.

Tedford RJ, Hemnes AR, Russell SD, Wittstein IS, Mahmud M, Zaiman AL, Mathai SC, Thiemann DR, Hassoun PM, Girgis RE, Orens JB, Shah AS, Yuh D, Conte JV, Champion HC.

Circ Heart Fail. 2008 Nov;1(4):213-9. doi: 10.1161/CIRCHEARTFAILURE.108.796789.

11.

Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models.

Koitabashi N, Bedja D, Zaiman AL, Pinto YM, Zhang M, Gabrielson KL, Takimoto E, Kass DA.

Circ Res. 2009 Jul 2;105(1):12-5. doi: 10.1161/CIRCRESAHA.109.198416. Epub 2009 Jun 11.

12.

Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience.

Barnett CF, Bonura EJ, Nathan SD, Ahmad S, Shlobin OA, Osei K, Zaiman AL, Hassoun PM, Moller DR, Barnett SD, Girgis RE.

Chest. 2009 Jun;135(6):1455-1461. doi: 10.1378/chest.08-1881. Epub 2008 Dec 31.

13.

Identification of candidate genes in scleroderma-related pulmonary arterial hypertension.

Grigoryev DN, Mathai SC, Fisher MR, Girgis RE, Zaiman AL, Housten-Harris T, Cheadle C, Gao L, Hummers LK, Champion HC, Garcia JG, Wigley FM, Tuder RM, Barnes KC, Hassoun PM.

Transl Res. 2008 Apr;151(4):197-207. doi: 10.1016/j.trsl.2007.12.010. Epub 2008 Feb 1.

14.

Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension.

Zaiman AL, Podowski M, Medicherla S, Gordy K, Xu F, Zhen L, Shimoda LA, Neptune E, Higgins L, Murphy A, Chakravarty S, Protter A, Sehgal PB, Champion HC, Tuder RM.

Am J Respir Crit Care Med. 2008 Apr 15;177(8):896-905. doi: 10.1164/rccm.200707-1083OC. Epub 2008 Jan 17.

17.

Supplemental Content

Loading ...
Support Center